Insider Shareholders with Direct Ownership of Taysha Gene Therapies, Inc. (TSHA)
This section provides a comprehensive overview of the insiders with direct ownership of Taysha Gene Therapies, Inc. (TSHA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Taysha Gene Therapies, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 293,814 | 549,095 | 8,871,747 $44.4 Million | 8 |
Jul 13, 2023
Reduced 0.06%
|
|
|
Sean P. Nolan
Chief Executive Officer |
2,078,358 | 0 | 2,078,358 $10.4 Million | 3 |
Jan 02, 2025
Added 30.04%
|
| 2,975,535 | 0 | 1,333,333 $6.67 Million | 7 |
Jun 27, 2024
Added 50.0%
|
|
|
Kamran Alam
CHIEF FINANCIAL OFFICER |
1,046,334 | 183,622 | 1,187,603 $5.94 Million | 15 |
Aug 21, 2025
Reduced 4.39%
|
| 544,732 | 0 | 1,155,224 $5.78 Million | 3 |
Jun 02, 2025
Added 4.67%
|
|
|
Sukumar Nagendran
President and Head of R&D |
1,263,493 | 257,054 | 1,006,439 $5.03 Million | 8 |
Sep 10, 2025
Reduced 16.58%
|
|
Suyash Prasad
CMO and Head of R&D |
3,844 | 142,000 | 530,589 $2.65 Million | 9 |
Jul 06, 2022
Reduced 1.66%
|
| 219,954 | 0 | 219,954 $1.1 Million | 4 |
Jun 02, 2025
Added 20.47%
|
|
| 105,843 | 0 | 105,843 $529,215 | 2 |
Jun 02, 2025
Added 34.85%
|
|
| 105,843 | 0 | 105,843 $529,215 | 2 |
Jun 02, 2025
Added 34.85%
|